NCT00366340 - Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. | Biotech Hunter

Enrollment

604

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Vaccines, Pneumococcal

Interventions

BIOLOGICAL

13-valent pneumococcal conjugate vaccine

Single 0.5mL dose given at 2, 3, 4 and 11 to 12 months of age

BIOLOGICAL

7-valent pneumococcal conjugate vaccine

Single 0.5mL dose given at 2, 3, 4 and 11 to 12 months of age

Trial Locations (51)

10551

Berlin

10967

Berlin

13355

Berlin

13409

Berlin

13507

Berlin

13627

Berlin

22763

Hamburg

23568

Lübeck

24111

Kiel

24534

NeumÃ¼nster

Neumünster

24939

Flensburg

25899

Niebüll

32427

Minden

32457

Porta Westfalica

34246

Vellmar

37269

Eschwege

47533

Kleve

47798

Krefeld

48159

Münster

48165

Münster

49565

Bramsche

55101

Mainz

55239

Gau-Odernheim

55543

Bad Kreuznach

55566

Bad Sobernheim

65205

Wiesbaden

67059

Ludwigshafen

72555

Metzingen

73642

Welzheim

75015

Bretten

75172

Pforzheim

75217

Birkenfeld

77694

Kehl

77704

Oberkirch

82140

Olching

82362

Weilheim

86399

Bobingen

88069

Tettnang

88214

Ravensburg

88348

Bad Saulgau

89584

Ehingen

90473

Nuremberg

90482

Nuremberg

90513

Zirndorf

91056

Erlangen

91074

Herzogenaurach

91413

Neustadt/Aisch

92637

Weiden

93413

Cham

97204

Höchberg

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY